(Q36222900)

12 August 2017

The changing face of chronic illness management in primary care: a qualitative study of underlying influences and unintended outcomes (English)

1 reference

12 August 2017

Linda M Hunt

1

1 reference

12 August 2017

Meta Kreiner

series ordinal

2

1 reference

12 August 2017

Howard Brody

series ordinal

3

1 reference

12 August 2017

language of work or name

English

0 references

publication date

1 September 2012

1 reference

Annals of Family Medicine

12 August 2017

1 reference

12 August 2017

10

1 reference

12 August 2017

5

1 reference

12 August 2017

452-460

1 reference

Long-term effects of intensive glucose lowering on cardiovascular outcomes

12 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3438213

Effect of pay for performance on the management and outcomes of hypertension in the United Kingdom: interrupted time series study

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3438213

Prescription drug use continues to increase: U.S. prescription drug data for 2007-2008

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3438213

Hidden complexities in assessment of glycemic outcomes: are quality rankings aligned with treatment?

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3438213

Tight blood pressure control and cardiovascular outcomes among hypertensive patients with diabetes and coronary artery disease

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3438213

New diabetes HEDIS blood pressure quality measure: potential for overtreatment

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3438213

Standards of medical care in diabetes--2010.

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3438213

Lessons from evaluations of purchaser pay-for-performance programs: a review of the evidence

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3438213

Polypharmacy: misleading, but manageable

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3438213

The cost of pushing pills: a new estimate of pharmaceutical promotion expenditures in the United States

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3438213

Treatment of hypertension in the prevention and management of ischemic heart disease: a scientific statement from the American Heart Association Council for High Blood Pressure Research and the Councils on Clinical Cardiology and Epidemiology and Pr

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3438213

Polypharmacy as commonly defined is an indicator of limited value in the assessment of drug-related problems

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3438213

Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3438213

The search for value in health care: a review of the National Committee for Quality Assurance efforts

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3438213

Relationships between authors of clinical practice guidelines and the pharmaceutical industry

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3438213

Optimising drug treatment for elderly people: the prescribing cascade

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3438213

Survival as a function of HbA(1c) in people with type 2 diabetes: a retrospective cohort study

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3438213

The inverse benefit law: how drug marketing undermines patient safety and public health.

29 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3438213

Physician professionalism and changes in physician-industry relationships from 2004 to 2009.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3438213

Recent trends in the prevalence of high blood pressure and its treatment and control, 1999-2008.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3438213

Severe hypoglycemia and risks of vascular events and death

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3438213

Prevalence of selected risk behaviors and chronic diseases and conditions-steps communities, United States, 2006-2007

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3438213

Assessing the 'relative value' of diabetic patients treated through an incentivized, corporate compliance model

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3438213

Getting to yes: corporate power and the creation of a psychopharmaceutical blockbuster

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3438213

Physician response to patient reports of adverse drug effects: implications for patient-targeted adverse effect surveillance.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3438213

Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3438213

The privatization of risk

22 September 2018

1 reference

12 December 2020

Conflicts of interest in cardiovascular clinical practice guidelines

1 reference

12 December 2020

New diabetes guidelines: a closer look at the evidence

1 reference

12 December 2020

Pay for performance in Medicare: evidentiary irony and the politics of value

1 reference

12 December 2020

The law of diminishing returns in clinical medicine: how much risk reduction is enough?

1 reference

12 December 2020

Identifiers

DOI

10.1370/AFM.1380

1 reference

12 August 2017

1 reference

12 August 2017

PubMed publication ID

22966109

1 reference